<DOC>
	<DOC>NCT00367692</DOC>
	<brief_summary>To evaluate the safety of an orally administered single dose of PSI-697 in subjects with scleritis, as a model of inflammatory disease. To evaluate by in vivo confocal microscopy (IVCM) the effect of a single dose of PSI-697 on leukocyte rolling in the scleral blood vessels of subjects with scleritis.</brief_summary>
	<brief_title>Study Evaluating PSI-697 in Patients With Scleritis</brief_title>
	<detailed_description />
	<mesh_term>Scleritis</mesh_term>
	<criteria>Inclusion: Age 18 or higher; A negative urine pregnancy test at screening for female subjects; Female subjects must be postmenopausal or surgically sterile. Exclusion: Isolated episcleritis; Isolated posterior scleritis; Infectious scleritis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Scleritis</keyword>
</DOC>